https://doi.org/10.4081/aiua.2026.14702
Metabolic and surgical predictors in horseshoe and pelvic ectopic kidneys
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Published: 17 February 2026
Background: Horseshoe kidney (HSK) and pelvic ectopic kidney (PEK) are congenital anomalies linked to impaired urinary drainage and a higher risk of nephrolithiasis. Evidence regarding metabolic profiles and surgical outcomes in these groups remains sparse. This study assessed predictors of postoperative stone clearance and 12-month recurrence in patients with HSK and PEK undergoing endourological procedures intervention.
Methods: We conducted a retrospective analysis of 50 consecutive patients with CT-confirmed HSK or PEK treated with retrograde intrarenal surgery (RIRS) or mini-percutaneous nephrolithotomy (mini-PNL) over 12 months. All patients had a standardized 24-hour metabolic evaluation and imaging followup at 1, 6, and 12 months. Outcomes included stone-free status at one month and recurrence at one year. Predictors were assessed using univariable and multivariable logistic regression.
Results: Stone-free status at 1 month was achieved in 62% of patients, with 22% having residual fragments ≥4 mm. Residual burden was strongly associated with recurrence, which occurred in 44% of the cohort. Patients with fragments ≥4 mm had the highest recurrence rate (72.7%), compared with 35.5% among stone-free individuals (p=0.047). Age was independently associated with reduced likelihood of achieving stone-free status (B = -0.069, p=0.011). Higher 24-hour urinary volume was the only biochemical parameter protective against recurrence (OR 0.243, p=0.039). Neither malformation type nor surgical technique significantly influenced postoperative outcomes or recurrence. Metabolic abnormalities were frequent but not predictive of stone type or recurrence.
Conclusions: In HSK and PEK, postoperative residual fragments and low urine volume are the main determinants of recurrence, whereas anatomical subtype and surgical approach have limited prognostic value. Strategies focused on complete stone clearance and hydration optimization may improve long-term outcomes in this patient population.
Downloads
1. Evans WP, Resnick MI. Horseshoe kidney and urologic anomalies. Urol Clin North Am 1978; 5:75-88.
2. Yoon Y, Lee YJ, Jung H, et al. The surgical outcome of ureteroscopy for nephrolithiasis in pelvic kidneys. Investig Clin Urol 2020; 61:379-84.
3. Gupta M, Cha K. Stones in exceptional situations: management of stones in patients with renal anomalies. Asian J Urol 2013; 1:10-7.
4. Legemate JD, Zanetti SP, Giusti G, et al. Ureteroscopic treatment of renal stones in anomalous kidneys: results from the CROES URS global study. J Urol 2017; 198:43-9.
5. Ozmerdiven G, Akca O, Sancaktutar AA, et al. Outcomes of retrograde intrarenal surgery in anomalous kidneys: predictors of success and complications. World J Urol 2023; 41:453-9.
6. Lim EJ, Mahapatra R, Shah A, et al. Outcomes of RIRS and PCNL in horseshoe and ectopic kidneys: a multicenter study. J Endourol 2022; 36:1151-8.
7. Eryildirim B, Tuncer M, Sahin C, et al. Retrograde intrarenal surgery versus percutaneous nephrolithotomy in horseshoe kidneys: a comparative study. Turk J Urol 2018; 44:105-9.
8. Kartal I, Sofikerim M, Demirci D, et al. Outcomes of PCNL in patients with horseshoe kidneys. Urolithiasis 2019; 47:259-65.
9. Senocak C, Ozden E, Demir A, et al. Percutaneous nephrolithotomy in horseshoe kidneys: does it differ from normal anatomy? Urol Res 2019; 47:493-8.
10. Karaolides T, Bach C, Kachrilas S, et al. The efficacy and safety of PCNL in horseshoe kidneys: a matched case-control study. J Endourol 2011; 25:949-53.
11. Assimos D, Krambeck A, Miller NL, et al. Metabolic evaluation of stone disease: a AUA guideline. J Urol 2016; 196:1244-52. DOI: https://doi.org/10.1016/j.juro.2016.05.091
12. Borghi L, Meschi T, Amato F, et al. Urine volume: a key factor in stone disease prevention. N Engl J Med 2002; 347:2102-7.
13. Worcester EM, Coe FL. Clinical practice: calcium kidney stones. N Engl J Med 2010; 363:954-63. DOI: https://doi.org/10.1056/NEJMcp1001011
14. Pearle MS, Goldfarb DS, Assimos DG, et al. Medical management of kidney stones: AUA guideline. J Urol 2014; 192:316-24. DOI: https://doi.org/10.1016/j.juro.2014.05.006
15. Bansal P, Bansal N, Sehgal A, et al. Flexible ureteroscopy for lower calyceal stones in a horseshoe kidney: is it the new treatment of choice? Afr J Urol 2016;22:179-83. DOI: https://doi.org/10.1016/j.afju.2016.01.007
16. Lavan L, Herrmann T, Netsch C, et al. Outcomes of ureteroscopy for stone disease in anomalous kidneys: a systematic review. World J Urol 2020; 38:1135-46. DOI: https://doi.org/10.1007/s00345-019-02810-x
17. Yitgin Y, Altınkaya N, Turaliev N, et al. Evaluation of the optimal duration for retrograde intrarenal stone surgery to prevent postoperative complications. Scott Med J 2022; 67:121-5. DOI: https://doi.org/10.1177/00369330221099621
18. Cao Z, Xiu Y, Yu D, et al. Clinical value of mixed reality-assisted puncture navigation for percutaneous nephrolithotripsy. Urology 2023; 176:219-25. DOI: https://doi.org/10.1016/j.urology.2022.12.067
19. Khadgi S, Shrestha B, Ibrahim H, et al. Mini-percutaneous nephrolithotomy for stones in anomalous kidneys: a prospective study. Urolithiasis 2017; 45:407-14. DOI: https://doi.org/10.1007/s00240-016-0926-1
20. Gupta NP, Mishra S, Seth A, et al. Percutaneous nephrolithotomy in abnormal kidneys: single-center experience. Urology 2009;73:710-5. DOI: https://doi.org/10.1016/j.urology.2008.10.070
21. Wu J, Shen J. The safety and efficacy of mini-percutaneous nephrolithotomy vs. retrograde intrarenal surgery for treatment of renal lithiasis in pelvic ectopic kidney: an exploratory pilot study. Transl Androl Urol 2021; 10:1734-42. DOI: https://doi.org/10.21037/tau-21-77
22. Polanco Pujol L, Bueno Chomon G, Caño Velasco J, et al. Laparoscopic pyelolithotomy in pelvic ectopic kidney: case report and literature review. Actas Urol Esp 2021; 45:419-26. DOI: https://doi.org/10.1016/j.acuroe.2020.09.007
23. Purkait B, Sinha RJ, Bansal A, et al. What is the fate of insignificant residual fragment following percutaneous nephrolithotomy in pediatric patients with anomalous kidney? A comparison with normal kidney. Urolithiasis 2018; 46:285-90. DOI: https://doi.org/10.1007/s00240-017-0980-3
24. Duvdevani M, Sfoungaristos S, Bensalah K, et al. Stones in special situations. World J Urol 2017; 35:1381-93. DOI: https://doi.org/10.1007/s00345-017-2011-y
25. Papatsoris A, Geavlete B, Radavoi GD, et al. Management of urinary stones by experts in stone disease (ESD 2025). Arch Ital Urol Androl 2025; 97:14085. DOI: https://doi.org/10.4081/aiua.2025.14085
26. Daudon M, et al. Serial crystalluria determination and the risk of recurrence in calcium stone formers. Kidney Int 2005; 67:1934-43. DOI: https://doi.org/10.1111/j.1523-1755.2005.00292.x
27. Shpitzer SA, Shpunt I, Loebl N, et al. Risk stratification for repeat stone surgery: the role of stone composition. World J Urol 2025;43:203-8. DOI: https://doi.org/10.1007/s00345-025-05573-w
28. Ahlstrand C, Tiselius HG. Recurrences during a 10-year followup after first renal stone episode. Urol Res 1990;18:397-9. DOI: https://doi.org/10.1007/BF00297372
29. Golomb D, Nevo A, Goldberg H, et al. Long-term adherence to medications in secondary prevention of urinary tract stones. J Endourol 2019;33:469-74. DOI: https://doi.org/10.1089/end.2019.0040
Supporting Agencies
This research was financially supported by the Academy of Romanian Scientists (AOSR), Bucharest, Romania (project code Ilfov 3, 050044)Data Availability Statement
The datasets generated and analyzed during this study are not publicly available because of patient privacy and institutional data protection policies. However, they can be obtained from the corresponding author upon reasonable request.
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.